Cancer Medicine · 2021 · 10 citations · 49 references
MedicineOncologySurgeryGastrointestinal OncologyMetastasisSurgical OncologyCancer Survival AnalysisColorectal CancerLiver CancerLiver MetastasisMetastatic Gastrointestinal CancerPrognostic AssessmentColorectal Cancer PrognosisColorectal Liver MetastasisCox RegressionLiver Disease PrognosisLiver Metastasis ResectionPrognostic Factors AnalysisPrognostic IndicesSurvival Rates
BACKGROUND: The prognostic value of lactate dehydrogenase (LDH) in colorectal cancer patients has remained inconsistent between nonmetastatic and metastatic settings. So far, very few studies have included LDH in the prognostic analysis of curative-intent surgery for colorectal liver metastases (CRLM). PATIENTS AND METHODS: Five hundred and eighty consecutive metastatic colorectal cancer patients who underwent curative-intent CRLM resection from Sun Yat-sen University Cancer Center (434 patients) and Sun Yat-sen University Sixth Affiliated Hospital (146 patients) in 2000-2019 were retrospectively collected. Overall survival (OS) was the primary end point. Cox regression model was performed to identify the prognostic values of preoperative serum LDH levels and other clinicopathology variables. A modification of the established Fong CRS scoring system comprising LDH was developed within this Chinese population. RESULTS: At the median follow-up time of 60.5 months, median OS was 59.5 months in the pooled cohort. In the multivariate analysis, preoperative LDH >upper limit of normal (250 U/L) was the strongest independent prognostic factor for OS (HR 1.73, 95% confidence interval [CI], 1.22-2.44; p < 0.001). Patients with elevated LDH levels showed impaired OS than patients with normal LDH levels (27.6 months vs. 68.8 months). Five-year survival rates were 53.7% and 22.5% in the LDH-normal group and LDH-high group, respectively. Similar results were also confirmed in each cohort. In the subgroup analysis, LDH could distinguish the survival regardless of most established prognostic factors (number and size of CRLM, surgical margin, extrahepatic metastases, CEA, and CA19-9 levels, etc.). Integrating LDH into the Fong score contributed to an improvement in the predictive value. CONCLUSION: Our study implicates serum LDH as a reliable and independent laboratory biomarker to predict the clinical outcome of curative-intent surgery for CRLM. Composite of LDH and Fong score is a potential stratification tool for CRLM resection. Prospective, international studies are needed to validate these results across diverse populations.
49
Global cancer statistics, 2012
Lindsey A. Torre, Freddie Bray, Rebecca L. Siegel et al. · CA A Cancer Journal for Clinicians · 2015 · 27.4K citations · Full text
Clinical Score for Predicting Recurrence After Hepatic Resection for Metastatic Colorectal Cancer
Yuman Fong, Joseph G. Fortner, Ruth L. Sun et al. · Annals of Surgery · 1999 · 3.7K citations · Full text
Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?
Ruimei Feng, Yi‐Nan Zong, Su‐Mei Cao et al. · Cancer Communications · 2019 · 1.7K citations · Full text
Medicine, Oncology, Cancer Control +13
Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics
Kathleen A. Cronin, Andrew Lake, Susan Scott et al. · Cancer · 2018 · 1.5K citations · Full text